author-photo

Anas Younes

University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center

656

Papers

25666

Citations

Citation Trend

Filter By

Papers (656) Sort By

Journal Conference Others

Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
PK and PD Assessment of BET Inhibitor Pelabresib (CPI-0610) in Patients with Relapsed or Refractory Lymphoma: Findings from a Phase 1 Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Epigenetics of T‐cell Lymphoma

2021
Show All
- Source
- Cite
- Save
Citations (1)
Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemo-radioimmunotherapy followed by autologous stem cell rescue

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
TP53 Mutations and RNA Binding Protein Musashi 2 Drive Resistance to PRMT5-Targeted Therapy in B-Cell Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY-STAGE FOLLICULAR LYMPHOMA

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Interim Efficacy Analysis of a Phase II Study Demonstrates Promising Activity of the Combination of Pembrolizumab (PEM) and Entinostat (ENT) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (HL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (3)